AstraZeneca sells COPD drugs for $270M
November 4, 2021
WILMINGTON – Pharmaceutical giant AstraZeneca sold the rights to two of its drugs used in the treatment of chronic obstructive pulmonary disease (COPD) for $270 million, the company announced Nov. […]
chat_bubble0 Comment
visibility995 Views
Premier Digital Partners
© 2023 Delaware Business Times
